Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Multiple Myeloma × ferric pyrophosphate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1

Interventions

Dexamethasone 116 Lenalidomide 65 Bortezomib 64 Cyclophosphamide 61 Calcium Dobesilate 46 fludarabine 39 pomalidomide 35 daratumumab 35 carfilzomib 30 Melphalan 25 fludarabine phosphate 24 dexamethasone acetate 18 dexamethasone 21-phosphate 18 auricularum 16 Filgrastim 16 Whole-Body Irradiation 14 Biopsy 13 Vorinostat 12 Magnetic Resonance Spectroscopy 12 isatuximab 11 Specimen Handling 11 Peripheral Blood Stem Cell Transplantation 11 Tacrolimus 10 Sirolimus 10 Panobinostat 10 Granulocyte Colony-Stimulating Factor 10 venetoclax 9 ixazomib 9 belantamab mafodotin 9 Rituximab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03506802 2020-07-24

NYSCT MM

Jonsson Comprehensive Cancer Center

Phase 1 Withdrawn

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡